2m 2m 2m 2m 2m 2m 2m
RELAY THERAPETCS (RLAY)
NASDAQ
$17.35+$0.07 (+0.41%)
Price as of Jun 23, 2026 11:43 AM EDT- $3.8BMarket Cap
- 434.98%1-Year Change
- BiotechnologyIndustry
RELAY THERAPETCS (RLAY)
$17.35+$0.07 (+0.41%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 15.4M +53.44% | 10.0M -60.83% | 25.5M +1,749.82% | 1.4M -95.44% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 15.4M +53.44% | 10.0M -60.83% | 25.5M +1,749.82% | 1.4M -95.44% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -261.4M -18.08% | -319.1M -3.31% | -330.0M -10.65% | -369.4M +24.93% | |
Depreciation and Amortization Expense | 3.6M -34.90% | 5.5M +3.70% | 5.3M +27.58% | 4.1M +5.22% | |
Total Operating Expenses | 318.1M -16.83% | 382.5M -4.03% | 398.5M +32.56% | 300.7M -18.24% | |
Operating Profit | -302.7M -18.72% | -372.5M -0.14% | -373.0M +24.63% | -299.3M -17.94% | |
Interest Income | 27.0M -22.19% | 34.7M +11.92% | 31.0M +253.35% | 8.8M +958.55% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 27.0M -22.19% | 34.7M +11.92% | 31.0M +253.35% | 8.8M +958.55% | |
Total Nonoperating Income and Expense | -776,000 -5,642.86% | 14,000 +177.78% | -18,000 -10.00% | -20,000 -102.42% | |
Income before Taxes | -302.7M -18.72% | -372.5M -0.14% | -373.0M +24.63% | -299.3M -17.75% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -276.5M -18.13% | -337.7M -1.25% | -342.0M +17.72% | -290.5M -20.16% | |
Net Income from Continuing Operations Applicable to Common | -276.5M -18.13% | -337.7M -1.25% | -342.0M +17.72% | -290.5M -20.16% | |
Basic EPS and Net Income | -1.61 -31.78% | -2.36 -15.41% | -2.79 +7.72% | -2.59 -32.20% | |
Diluted EPS and Net Income | -1.61 -31.78% | -2.36 -15.41% | -2.79 +7.72% | -2.59 -32.20% | |
Basic Weighted Average Shares | 171.6M +20.10% | 142.9M +16.55% | 122.6M +9.22% | 112.2M +17.97% | |
Diluted Weighted Average Shares | 171.6M +20.10% | 142.9M +16.55% | 122.6M +9.22% | 112.2M +17.97% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 84.0M -32.40% | 124.3M -13.53% | 143.7M -5.31% | 151.8M -45.81% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 84.0M -32.40% | 124.3M -13.53% | 143.7M -5.31% | 151.8M -45.81% | |
Total Current Assets | 578.3M -28.54% | 809.2M +5.08% | 770.1M -24.46% | 1.0B +4.43% | |
Accumulated Depreciation | 21.5M -25.47% | 28.9M +22.60% | 23.6M +28.24% | 18.4M +27.99% | |
Property and Plant and Equipment and Net | 1.7M -70.80% | 5.9M -45.78% | 10.9M -6.30% | 11.6M +77.81% | |
Total Long-Term Assets | 1.7M -70.80% | 5.9M -45.78% | 10.9M -6.30% | 11.6M +52,781.82% | |
Total Assets | 621.3M -28.69% | 871.3M +3.24% | 844.0M -23.26% | 1.1B +9.06% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 25.6M -49.58% | 50.7M +67.59% | 30.3M -52.49% | 63.7M +161.95% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 28.7M -32.92% | 42.8M -11.81% | 48.5M +223.35% | 15.0M 0.00% | |
Total Liabilities | 54.3M -41.96% | 93.5M +1.66% | 92.0M -38.50% | 149.6M +35.18% | |
Retained Earnings | -2.0B +15.91% | -1.7B +24.11% | -1.4B +32.30% | -1.1B +37.82% | |
Total Stockholders Equity | 567.1M -27.09% | 777.8M +3.43% | 752.0M -20.86% | 950.2M +5.84% | |
Total Shares Outstanding | 173.9M +3.64% | 167.8M +31.61% | 127.5M +5.24% | 121.1M +11.92% | |
Cash Flow | |||||
Cash from Operating Activities | -235.5M -5.48% | -249.1M -17.05% | -300.3M +30.86% | -229.5M +208.43% | |
Capital Expenditures | 410,000 -79.68% | 2.0M -51.09% | 4.1M -54.47% | 9.1M +161.08% | |
Cash from Investing Activities | 192.8M +569.29% | -41.1M -115.95% | 257.6M +236.50% | -188.7M -60.64% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 1.6M -99.41% | 270.2M +677.35% | 34.8M -88.01% | 289.9M -25.30% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -1,971.59% -47.03% | -3,722.07% +154.92% | -1,460.11% -93.26% | -21,670.89% +1,699.88% | |
Return on Assets | -37.05% -5.92% | -39.38% +11.91% | -35.19% +27.68% | -27.56% -31.52% | |
Return on Equity | -41.12% -6.87% | -44.15% +9.88% | -40.18% +27.80% | -31.44% -28.24% | |
Revenue Growth | 53.44% +187.86% | -60.83% -103.48% | 1,749.82% +1,933.41% | -95.44% +50.65% | |
Current Ratio | 22.61 +41.73% | 15.95 -37.30% | 25.44 +58.99% | 16.00 -60.13% | |
Cash Ratio | 3.28 +34.07% | 2.45 -48.41% | 4.75 +99.30% | 2.38 -79.31% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow